The Relationship Between Admission Insulin Resistance Index (AIRI) and In-Hospital Outcome in Non-Diabetic Acute Coronary Syndrome
DOI:
https://doi.org/10.15605/jafes.038.01.03Keywords:
insulin resistance, acute coronary syndrome, in-hospital outcome, AIRIAbstract
Background. Acute coronary syndrome (ACS) is a major cardiovascular problem due to its high hospitalization and mortality rates. One of the risk factors for atherosclerosis that leads to ACS is insulin resistance (IR) which plays a role in the pathogenesis and development of cardiovascular events. This study aims to determine the relationship between IR and in-hospital outcomes in non-diabetic patients with ACS.
Methodology. This was a cohort study conducted from January-June 2021. Insulin resistance was assessed using the Admission insulin resistance index (AIRI). This measurement was performed once during the patient's admission, and then the outcome was observed during hospitalization. The observed in-hospital outcomes were composite outcomes; namely, heart failure, arrhythmia, cardiogenic shock, and death. The statistical tests used were ANOVA, independent T and Chi-Square tests. Statistical test results were considered significant if p<0.05.
Results. This study included 60 subjects (51 males and 9 females). Analysis revealed that AIRI was higher in patients with composite outcomes (mean 9.97 ± 4.08) than in patients without composite outcomes (mean 7.71 ± 4.06) (p<0.05); AIRI was higher in patients with heart failure (mean 10.72 ± 3.83) than in patients without heart failure (mean 7.25 ± 3.84) (p<0.001). Patients with IR had a higher rate of heart failure complications [OR 5.5 95% CI (1.56-19.38) (p=0.005)].
Conclusion. There is an association between AIRI and composite outcomes. Patients with IR have 5.5 times the risk of developing heart failure.
Downloads
References
Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26(2):19-39. https://pubmed.ncbi.nlm.nih.gov/16278749. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1204764.
Caccamo G, Bonura F, Bonura F, et al. Insulin resistance and acute coronary syndrome. Atherosclerosis. 2010;211(2):672-5. https://pubmed.ncbi.nlm.nih.gov/20466373. https://doi.org/10.1016/j.atherosclerosis.2010.03.033.
Semenkovich CF. Insulin Resistance and atherosclerosis. J Clin Invest. 2006;116(7):1813-22. https://pubmed.ncbi.nlm.nih.gov/16823479. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483180. https://doi.org/10.1172/JCI29024.
Hacman DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: A critical review of the evidence. Clin Cardiol. 2003;290(7):932-40. https://pubmed.ncbi.nlm.nih.gov/12928471. https://doi.org/10.1001/jama.290.7.932.
Razani B, Chakravarthy MV, Semenkovich CF. Insulin resistance and atherosclerosis. Endocrinol Metab Clin North Am. 2008;37(3):603-21. https://pubmed.ncbi.nlm.nih.gov/18775354. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639785. https://doi.org/10.1016/j.ecl.2008.05.001.
Refaie W, Elewa A. Admission insulin resistance index in non diabetic patients with acute coronary syndrome: Clinical and angiographic features. Egypt J Intern Med. 2013;25:42-6. https://doi.org/10.7123/01.EJIM.0000425959.76987.c5.
Stubbs PJ, Alaghband-Zadeh J, Laycock JF, Collinson PO, Carter GD, Noble MI. Significance of an index of insulin resistance on admission in non-diabetic patients with acute coronary syndromes. 1999;82(4):443-7. https://pubmed.ncbi.nlm.nih.gov/10490558. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760262. https://doi.org/10.1136/hrt.82.4.443.
Içli A, Gök H, Altunkeser BB, et al. Evaluation of “admission index of insulin resistance (AIRI)” as an early stage risk predictor in nondiabetic acute coronary syndromes. Anadolu Kardiyol Derg. 2002;2(3):194-201. https://pubmed.ncbi.nlm.nih.gov/12223324.
Sanjuan R, Blasco ML, Huerta R, et al. Insulin resistance and short-term mortality in patients with acute myocardial infarction. Int J Cardiol. 2014;172(2):e269-70. https://pubmed.ncbi.nlm.nih.gov/24485226. https://doi.org/10.1016/j.ijcard.2013.12.207.
Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A. Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab. 2015;19(1):160-4. https://pubmed.ncbi.nlm.nih.gov/25593845. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287763. https://doi.org/10.4103/2230-8210.146874.
Souza AL, Batista GA, Alegre SM. Assessment of insulin sensitivity by the hyperinsulinemic euglycemic clamp: Comparison with the spectral analysis of photoplethysmography. J Diab Complications. 2017;31(1):128-33. https://pubmed.ncbi.nlm.nih.gov/27839921. https://doi.org/10.1016/j.jdiacomp.2016.10.018.
Horáková D, Štěpánek L, Jonout V, et al. Optimal homeostasis model assessment of insulin resistance (HOMA-IR) cut-offs: A cross-sectional study in the Czech Population. Medicine (Kaunas). 2019;55(5):158. https://pubmed.ncbi.nlm.nih.gov/31108989. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571793. https://doi.org/10.3390/medicina55050158.
Dash K, Goodacre S, Sutton L. Composite outcomes in clinical prediction modeling: Are we trying to predict apples and oranges? Ann Emerg Med. 2022;80(1):12-9. https://pubmed.ncbi.nlm.nih.gov/35339284. https://doi.org/10.1016/j.annemergmed.2022.01.046.
Ponikowski P, Voors AA, Anker SA, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology ( ESC ) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200. https://pubmed.ncbi.nlm.nih.gov/27206819. https://doi.org/10.1093/eurheartj/ehw128.
Vahdatpour C, Collins D, Goldberg S. Cardiogenic shock. J Am Heart Assoc. 2019;8(8):e011991. https://pubmed.ncbi.nlm.nih.gov/30947630. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507212. https://doi.org/10.1161/JAHA.119.011991.
Yun KH, Jeong MH, Kim KH, et al. The effect of insulin resistance on prognosis of non-diabetic patients who underwent percutaneous coronary intervention. J Korean Med Sci. 2006;21(2):212-6. https://pubmed.ncbi.nlm.nih.gov/16614503. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733993. https://doi.org/10.3346/jkms.2006.21.2.212.
Salehiomran MT, Jafari S. Association of admission insulin resistance index with early cardiac complications in non diabetic patients with acute coronary syndrome. J Babol Univ Med Sci. 2009;10(6):62-6.
Aroor AR, Mandavia CH, Sowers JR. Insulin resistance and heart failure: Molecular mechanisms. Heart Fail Clin. 2012;8(4):609-17. https://pubmed.ncbi.nlm.nih.gov/22999243. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457065. https://doi.org/10.1016/j.hfc.2012.06.005.
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. https://pubmed.ncbi.nlm.nih.gov/30170598. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119242. https://doi.org/10.1186/s12933-018-0762-4.
Juzar DA, Danny SS, Irmalita, Firdaus I, Widyantoro B. Pedoman Tatalaksana Sindrom Koroner Akut. 4th ed. Jakarta:PERKI; 2018..
Sanjuan R, Blasco ML, Martinez-maicas H, et al. Acute myocardial infarction : High risk ventricular tachyarrhythmias and admission glucose level in patients with and without diabetes mellitus. Curr Diabetes Rev. 2011;7(2):126-34. https://pubmed.ncbi.nlm.nih.gov/21348814. https://doi.org/10.2174/157339911794940675.
O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation, 2013;127(4):e362.425. https://pubmed.ncbi.nlm.nih.gov/23247304. https://doi.org/10.1161/CIR.0b013e3182742cf6.
Lazzeri C, Sori A, Chiostri M, Gensini GF, Valente S. Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol. 2009;26(10):856-62. https://pubmed.ncbi.nlm.nih.gov/19367169. https://doi.org/10.1097/EJA.0b013e32832a235c.
García RG, Rincón MY, Arenas WD, et al. Hyperinsulinemia is a predictor of new cardiovascular events in Colombian patients with a first myocardial infarction. Int J Cardiol. 2011;148(1):85-90. https://pubmed.ncbi.nlm.nih.gov/19923024. https://doi.org/10.1016/j.ijcard.2009.10.030.
Gast KB, Tjeerdema N, Stijnen T, Smit JWA, Dekkers OM. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: Meta-analysis. PLoS One. 2012;7(12):e52036. https://pubmed.ncbi.nlm.nih.gov/23300589. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532497. https://doi.org/10.1371/journal.pone.0052036.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Jorianto Muntari, Husaini Umar, Pendrik Tandean, Syakib Bakri, Himawan Sanusi, Nur Ahmad Tabri, Arifin Seweng
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.
